Download Brochure

Meetings Drive Business

Meetings Drive Business

Start Networking

linkedin
research gate
twitter
Future of Biopharma blog

Send To A Friend

Invite a colleague to join you at this event

Add Event To Calendar

Customer Service

Have a question
about this event?

Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200


Need Technical Assistance With this Website?
Send an email to
IIR's Web Department

Home

2009 Biorepositories Conference

The premier global event improving biospecimen storage, distribution, and tracking to protect, prove, and validate sample integrity throughout the entire drug development process - A strategic perspective on biorepository sample management.

IIR’s 2nd Annual Biorepositories event delivers an excellent speaking faculty of senior level scientists and industry experts who share new data and address your most pressing biobank challenges. The nation’s leading biobank experts gather annually at The Biorepository conference to cultivate a strategic perspective on biorepository sample management and discuss best practices for improving biospecimen storage, distribution, tracking, and sample procurement to protect, prove, and validate sample integrity throughout the entire drug development process. Join them this year to obtain:

  • Updates and direction on future industry guidelines and regulations for the biobank industry
  • Strategies to integrate the best and next industry practices into your biobank from the leading industry experts who are driving innovation in the biorepository field
  • Tools to implement new technologies and procedures for your biobank to be more time and cost efficient in this economy
  • Operational Strategies, Software Management Systems, Biospecimen Sample Integrity, Biospecimen Sample Procurement, Informed Consent Form Management, and Practical Solutions that will infuse new energy into your Biorepository.
  • Learn what measures you can put in place today at your company’s biorepository to generate future opportunities for your clinical practice.

No other event brings together more leading authorities in the biorepository industry and as biobank technology and procedures change and evolve everyday nothing can replace the face to face information exchange that happens. Meet with biobank experts in a non-competitive environment so that you can return to your company ready to implement the latest techniques in your biorepository to ensure your samples are ready for long term biospecimen storage.

2008 Testimonials

“The workshops appear to be at a threshold of a new topic in science and business that is only now just being addressed in standardizing the handling of samples.”
- Duncan Wallace, Gilead Sciences Inc.

“Excellent agenda”
- Marylee Garvey, Biogen Idec

“This is the first opportunity I have seen to get together with others who work in the field to discuss issues I worry about every day.”
- Sascha Ellers, Genentech

“It was a wonderful conference. It certainly improved my knowledge of many aspects around sample collections, storage, and shipping.”
- Joanna Thomas, Roche

“The mix of industry and academia was excellent.”
- 2008 attendee


Keep up with the Future of Biopharma Blog

  • Vical's H1N1 vaccines tested
    According to SignOnSanDiego.com, Vical has tested their H1N1 flu vaccines on animals, and found the tests to be successful. Their delivery method is unique, injecting genetic material, such as DNA or RNA, that expresses a protein that induces an imm...
  • Morphotek working with Synageva BioPharma
    The Philadelphia Business Journal reports that Morphotek Inc. said Wednesday that it will collaborate with Synageva BioPharma Corp. on the development of therapeutic monoclonal antibodies for the potential treatment of various forms of cancer and inf...
  • Generic Biotech is Coming to the US
    This post on the Wall Street Journal blog discusses that soon enough generic biotech drugs will be coming to the US. This is evident with the latest deal with Mylan, a Pennsylvania based generics shop, and Biocan, an Indian biotech company.Manufactur...
  • Could drug delivery methods prevent prescription abuse?
    In an article at PharmTech, they look at how changing drug delivery methods could prevent prescription drug abuse. While changing the drug delivery method could stop abusers from taking the prescriptions, it would allow the doses to be available to ...
  • Exclusivity period for biologics
    Obama believes that biologics should be able to face competition after seven years on the market instead of 12-14. Nancy-Ann DeParle, director of the Office of Health Reform, and Peter Orszag, director of the Office of Management and Budget wrote a l...
Subscribe to this feed.